Blockade of vascular endothelial growth factor sensitizes tumor-associated vasculatures to angiolytic therapy with a high-frequency ultrashort pulsed laser

Microvascular Research

Volumn 82, Issue 2, 2011, Pages 141-146

  Choi, Hyosook ^a   Choi, Myunghwan ^a   Choi, Kyungsun ^a   Choi, Chulhee ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER THERAPY; CELL LEVEL; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FEMTOSECOND LASER; HIGH FREQUENCY ULTRASHORT PULSE LASER; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VASCULAR TUMOR;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; CELL LINE, TUMOR; HUMANS; LASERS; MALE; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960922711     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.04.010     Document Type: Article

References (42)

1. Ando J., et al. Photogeneration of membrane potential hyperpolarization and depolarization in non-excitable cells. Eur. Biophys. J. 2009, 38:255-262.
2. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3:401-410.
3. Bergers G., Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8:592-603.
4. Bergers G., et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 2003, 111:1287-1295.
5. Bhawalkar J.D., et al. Two-photon photodynamic therapy. J. Clin. Laser Med. Surg. 1997, 15:201-204.
6. Boehm T., et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997, 390:404-407.
7. Browder T., et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 2000, 60:1878-1886.
8. Brown E.B., et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med. 2001, 7:864-868.
9. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
10. Casanovas O., et al. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005, 8:299-309.
11. Choi M., et al. Label-free optical control of arterial contraction. J. Biomed. Opt. 2010, 15:015006.
12. Clapp C., Martinez de la Escalera G. Aquaporin-1: a novel promoter of tumor angiogenesis. Trends Endocrinol. Metab. 2006, 17:1-2.
13. Dougherty T.J., et al. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90:889-905.
14. Du R., et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206-220.
15. Dvorak H.F., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995, 146:1029-1039.
16. Fisher W.G., et al. Simultaneous two-photon activation of type-I photodynamic therapy agents. Photochem. Photobiol. 1997, 66:141-155.
17. Folkman J., et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
18. Fu L., et al. Characterization of gradient-index lens-fiber spacing toward applications in two-photon fluorescence endoscopy. Appl. Opt. 2005, 44:7270-7274.
19. Geng L., et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res. 2001, 61:2413-2419.
20. Glade Bender J., et al. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist. Updat. 2004, 7:289-300.
21. Heisterkamp A., et al. Pulse energy dependence of subcellular dissection by femtosecond laser pulses. Opt. Express 2005, 13:3690-3696.
22. Hurwitz H., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 2004, 350:2335-2342.
23. Jacobson M.D. Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 1996, 21:83-86.
24. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
25. Kerbel R.S., et al. Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Rev. 2001, 20:79-86.
26. Kloppenburg P., et al. Highly localized Ca(2+) accumulation revealed by multiphoton microscopy in an identified motoneuron and its modulation by dopamine. J. Neurosci. 2000, 20:2523-2533.
27. Kobat D., et al. Deep tissue multiphoton microscopy using longer wavelength excitation. Opt. Express 2009, 17:13354-13364.
28. Kohli V., et al. Cell nanosurgery using ultrashort (femtosecond) laser pulses: applications to membrane surgery and cell isolation. Lasers Surg. Med. 2005, 37:227-230.
29. Konig K. Multiphoton microscopy in life sciences. J. Microsc. 2000, 200:83-104.
30. Lee C.G., et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 2000, 60:5565-5570.
31. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
32. Roodink I., Leenders W.P. Targeted therapies of cancer: angiogenesis inhibition seems not enough. Cancer Lett. 2010, 299:1-10.
33. Shaheen R.M., et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. 1999, 59:5412-5416.
34. Stadler I., et al. In vitro effects of low-level laser irradiation at 660nm on peripheral blood lymphocytes. Lasers Surg. Med. 2000, 27:255-261.
35. Stone J.R., Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002, 9:231-238.
36. Stuart B.C., et al. Nanosecond-to-femtosecond laser-induced breakdown in dielectrics. Phys. Rev. B Condens. Matter. 1996, 53:1749-1761.
37. Tran J., et al. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4349-4354.
38. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 2007, 9:731-739.
39. Ushio-Fukai M., Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008, 266:37-52.
40. Wachsberger P., et al. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin. Cancer Res. 2003, 9:1957-1971.
41. Wilson B.C., et al. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med. Sci. 1997, 12:182-199.
42. Zhu Q., et al. Photo-irradiation improved functional preservation of the isolated rat heart. Lasers Surg. Med. 1997, 20:332-339.